Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 20/20 | 0.62 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.44 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439478 | 1.00 | AKR1B1 (0.62) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL2106478 | 1.00 | AKR1B1 (0.62) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL2106476 | 1.00 | AKR1B1 (0.62) | AKR1B1AKR1B10AKR1A1 | |
| Hydrochloric Acid SCHEMBL10572099 | 0.99 | AKR1B1 (0.60) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10572287 | 0.88 | AKR1B1 (0.50) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10570947 | 0.86 | AKR1B1 (0.55) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10650030 | 0.86 | AKR1B1 (0.55) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10571180 | 0.86 | AKR1B1 (0.55) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10572034 | 0.86 | AKR1B1 (0.55) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL13335712 | 0.85 | AKR1B1 (0.61) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4841079-A | Process for the production of asymmetric hydantoins | PFIZER, INC. (US) | 1989-06-20 | — | — | US | claimed |
| EP-0172719-B1 | PROCESS FOR THE PRODUCTION AS ASYMMETRIC HYDANTOINS | PFIZER INC. (US) | 1988-09-21 | — | — | EP | claimed |
| US-4716113-A | Process for the production of an (S)-methyl or (S)-ethyl 4-amino-6-fluorochroman-4-carboxylate | PFIZER INC. (US) | 1987-12-29 | — | — | US | claimed |
| CN-85105869-A | The preparation method of asymmetric glycolylurea | — | 1987-01-28 | — | — | CN | claimed |
| EP-0172719-A1 | Process for the production as asymmetric hydantoins | PFIZER INC. (US) | 1986-02-26 | — | — | EP | claimed |
| US-8158667-B2 | Topical treatment of cataracts in dogs | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2012-04-17 | — | — | US | disclosed |
| WO-2010065024-A1 | TOPICAL TREATMENT OF CATARACTS IN DOGS | KADOR PETER F (US) | 2010-06-10 | — | — | WO | disclosed |
| US-20090082415-A1 | Topical treatment of cataracts in dogs | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2009-03-26 | — | — | US | disclosed |
| CN-1006794-B | PROCESS FOR THE PREPARATION OF ASYMMETRIC HYDANTOINS | PFIZER (US) | 1990-02-14 | — | — | CN | disclosed |
| US-4841079-A | Process for the production of asymmetric hydantoins | PFIZER, INC. (US) | 1989-06-20 | — | — | US | disclosed |
| EP-0172719-B1 | PROCESS FOR THE PRODUCTION AS ASYMMETRIC HYDANTOINS | PFIZER INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| US-4716113-A | Process for the production of an (S)-methyl or (S)-ethyl 4-amino-6-fluorochroman-4-carboxylate | PFIZER INC. (US) | 1987-12-29 | — | — | US | disclosed |
| CN-85105869-A | The preparation method of asymmetric glycolylurea | — | 1987-01-28 | — | — | CN | disclosed |
| EP-0172719-A1 | Process for the production as asymmetric hydantoins | PFIZER INC. (US) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082415-A1 | Topical treatment of cataracts in dogs | AKR1A1, AKR1B1, AKR1C1 | AKR1B1 2/4885AKR1B10 9/4885AKR1A1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.